IDEXX Laboratories

Quarterly Financials

Values in thousands2026-03-312025-12-312025-09-302025-06-30
Revenue
$1,140,820
$1,090,579
$1,105,239
$1,109,457
Gross Profit
722,739
658,114
683,354
694,732
EBITDA
362,586
356,219
392,053
409,445
EBIT
317,498
355,426
373,673
Net Income
278,446
248,188
274,610
293,989
Net Change In Cash
1,140,820
1,090,579
1,105,239
1,109,457
Free Cash Flow
234,264
322,588
371,226
151,641
Cash
200,528
180,070
208,166
164,594
Basic Shares
80,675
80,675
80,675
80,994

Annual Financials

Values in thousands2025-12-312024-12-312023-12-312022-12-31
Revenue
$4,303,702
$3,897,504
$3,660,953
$3,367,324
Gross Profit
2,659,579
2,378,927
2,189,970
2,004,338
EBITDA
1,468,916
1,275,840
1,097,128
1,010,665
EBIT
1,362,454
1,145,904
1,097,128
898,765
Net Income
1,059,464
887,867
845,042
679,089
Net Change In Cash
4,303,702
3,897,504
3,660,953
3,367,324
Cost of Revenue
-23,302
Free Cash Flow
1,053,391
798,079
772,879
394,146
Cash
180,070
288,266
453,932
112,546
Basic Shares
80,675
83,056
83,978
84,600

Earnings Calls

QuarterEPS
2026-03-31
$3.47
2025-12-31
$3.08
2025-09-30
$3.40
2025-06-30
$3.63